Dose Consideration of Lenvatinib's Anti-Cancer Effect on Hepatocellular Carcinoma and the Potential Benefit of Combined Colchicine Therapy.
Zu-Yau LinMing-Lun YehPo-Cheng LiangPo-Yao HsuChung-Feng HuangJee-Fu HuangChia-Yen DaiMing-Lung YuWan-Long ChuangPublished in: Cancers (2023)
Lenvatinib does not show a dose-dependent anti-cancer effect on HCC. Combined colchicine and lenvatinib can promote the total anti-cancer effects on HCC.